| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $0 | 0 | 0 |
Sells | $24,314,986 | 7 | 100 |
| Dixon Robert L JR | director | 0 | $0 | 1 | $154,562 | $-154,562 |
| Penczek Ronald W | CAO & Controller | 0 | $0 | 1 | $183,903 | $-183,903 |
| PERU RAMIRO G | director | 0 | $0 | 1 | $400,235 | $-400,235 |
| Kaye Mark | EVP & CFO | 0 | $0 | 1 | $1.95M | $-1.95M |
| Kendrick Charles Morgan JR | EVP & President, Commercial | 0 | $0 | 2 | $4.59M | $-4.59M |
| BOUDREAUX GAIL | President and CEO | 0 | $0 | 1 | $17.03M | $-17.03M |
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Over the last 12 months, insiders at Elevance Health Inc. have bought $0 and sold $24.31M worth of Elevance Health Inc. stock.
On average, over the past 5 years, insiders at Elevance Health Inc. have bought $501,460 and sold $24.52M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,300 shares for transaction amount of $499,668 was made by Schneider Ryan M. (director) on 2021‑07‑23.
| 2025-04-24 | Sale | Kaye Mark | EVP & CFO | 4,588 0.002% | $424.82 | $1.95M | -9.48% | |
| 2025-03-10 | Sale | Penczek Ronald W | CAO & Controller | 443 0.0002% | $415.13 | $183,903 | +1.77% | |
| 2025-03-05 | Sale | Kendrick Charles Morgan JR | EVP & President, Commercial | 3,504 0.0015% | $396.30 | $1.39M | +5.20% | |
| 2024-10-18 | Sale | Kendrick Charles Morgan JR | EVP & President, Commercial | 7,417 0.0034% | $432.14 | $3.21M | -6.48% | |
| 2024-08-05 | Sale | PERU RAMIRO G | director | 753 0.0004% | $531.52 | $400,235 | -20.88% | |
| 2024-07-22 | Sale | BOUDREAUX GAIL | President and CEO | 34,000 0.018% | $500.98 | $17.03M | -16.98% | |
| 2024-07-19 | Sale | Dixon Robert L JR | director | 305 0.0002% | $506.76 | $154,562 | -16.34% | |
| 2024-04-24 | Sale | Norwood Felicia F | EVP & President,Gov Health Ben | 6,199 0.0035% | $532.44 | $3.3M | -16.60% | |
| 2024-04-23 | Sale | Norwood Felicia F | EVP & President,Gov Health Ben | 14,111 0.008% | $533.74 | $7.53M | -16.20% | |
| 2024-03-08 | Sale | Kendrick Charles Morgan JR | EVP & President, Commercial | 2,432 0.0013% | $500.46 | $1.22M | +1.30% | |
| 2024-03-06 | Sale | Penczek Ronald W | CAO & Controller | 916 0.0005% | $504.58 | $462,195 | +1.21% | |
| 2024-03-04 | Sale | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | 21,095 0.0112% | $500.18 | $10.55M | +1.29% | |
| 2024-02-07 | Sale | PERU RAMIRO G | director | 753 0.0004% | $500.00 | $376,500 | +2.86% | |
| 2023-12-14 | Sale | Todt Blair Williams | EVP, CLO & CAO | 5,492 0.0028% | $484.02 | $2.66M | +6.70% | |
| 2023-11-30 | Sale | Penczek Ronald W | CAO & Controller | 1,055 0.0005% | $475.17 | $501,304 | +7.11% | |
| 2023-10-24 | Sale | Penczek Ronald W | CAO & Controller | 64 <0.0001% | $454.35 | $29,078 | +13.44% | |
| 2023-07-21 | Sale | Dixon Robert L JR | director | 310 0.0002% | $476.71 | $147,780 | +2.09% | |
| 2023-03-24 | Sale | MCCARTHY GLORIA M | EVP & Chief Administrative Off | 15,098 0.0071% | $444.76 | $6.71M | +2.11% | |
| 2023-03-09 | Sale | Kendrick Charles Morgan JR | EVP & President, Commercial | 2,314 0.0011% | $462.22 | $1.07M | +1.05% | |
| 2022-06-09 | Sale | Kendrick Charles Morgan JR | EVP & President, Commercial | 522 0.0003% | $490.83 | $256,213 | -1.20% |
| BOUDREAUX GAIL | President and CEO | 126709 0.0561% | $48.73M | 1 | 1 | +5.1% |
| Kaye Mark | EVP & CFO | 18977 0.0084% | $7.3M | 0 | 1 | |
| Kendrick Charles Morgan JR | EVP & President, Commercial | 10116 0.0045% | $3.89M | 0 | 5 | |
| Dixon Robert L JR | director | 9721 0.0043% | $3.74M | 0 | 7 | |
| PERU RAMIRO G | director | 8744 0.0039% | $3.36M | 0 | 15 | |
| Penczek Ronald W | CAO & Controller | 1847 0.0008% | $710,263.85 | 0 | 24 | |
| Beer Lori A | EVP, Specialty Businesses & IT | 113955 0.0504% | $43.82M | 0 | 2 | |
| NUSSBAUM SAMUEL R MD | EVP & Chief Medical Officer | 110973 0.0491% | $42.67M | 0 | 14 | |
| Cannon John | EVP, GC & Chief PAO | 99331 0.044% | $38.2M | 0 | 6 | |
| BAKER LENOX D JR MD | director | 71155 0.0315% | $27.36M | 0 | 2 | |
| Goulet Kenneth R | EVP, Commercial & Specialty | 71065 0.0315% | $27.33M | 0 | 5 | |
| DeVeydt Wayne S | EVP & Chief Financial Officer | 69607 0.0308% | $26.77M | 0 | 13 | |
| Swedish Joseph | Executive Chairman | 61419 0.0272% | $23.62M | 0 | 18 | |
| Sassi Brian A | President & CEO Cons, EVP | 60825 0.0269% | $23.39M | 2 | 2 | +15.57% |
| Gallina John E | EVP & Chief Financial Officer | 54320 0.024% | $20.89M | 0 | 6 | |
| MCCARTHY GLORIA M | EVP & Chief Administrative Off | 51435 0.0228% | $19.78M | 0 | 20 | |
| SCHAEFER GEORGE A JR | director | 33055 0.0146% | $12.71M | 0 | 2 | |
| HILL JULIE A | director | 31213 0.0138% | $12M | 0 | 10 | |
| JOBE WARREN Y | director | 30525 0.0135% | $11.74M | 0 | 3 | |
| Brown Randal L | EVP & Chief HR Officer | 30332 0.0134% | $11.66M | 0 | 3 | |
| Norwood Felicia F | EVP & President,Gov Health Ben | 27304 0.0121% | $10.5M | 0 | 2 | |
| RYAN WILLIAM J | director | 27149 0.012% | $10.44M | 0 | 5 | |
| Levine Harlan A | EVP, CHS | 25244 0.0112% | $9.71M | 0 | 1 | |
| ZORETIC RICHARD C | EVP, Gov Business Division | 24432 0.0108% | $9.4M | 0 | 2 | |
| Tomas Jose D. | EVP & Chief HR Officer | 23913 0.0106% | $9.2M | 0 | 1 | |
| WARD JACKIE M | director | 20860 0.0092% | $8.02M | 0 | 1 | |
| Haytaian Peter D | EVP & Pres Carelon & CarelonRx | 18887 0.0084% | $7.26M | 0 | 22 | |
| BUSH WILLIAM H T | director | 18302 0.0081% | $7.04M | 0 | 1 | |
| ZIELINSKI THOMAS C | EVP & General Counsel | 17910 0.0079% | $6.89M | 0 | 10 | |
| Samitt Craig E | EVP & President, DBG | 17274 0.0076% | $6.64M | 0 | 1 | |
| BURKE SHEILA P | director | 16200 0.0072% | $6.23M | 0 | 2 | |
| GRIFFIN BRIAN T | EVP & CEO, IngenioRx | 15863 0.007% | $6.1M | 0 | 1 | |
| Todt Blair Williams | EVP, CLO & CAO | 12512 0.0055% | $4.81M | 0 | 1 | |
| Schneider Ryan M. | director | 4714 0.0021% | $1.81M | 2 | 0 | +24.64% |
| BAYH SUSAN B | director | 0 0% | $0 | 0 | 2 | |
| LOGEN ASSET MANAGEMENT LP | 10 percent owner | 0 0% | $0 | 0 | 1 |
Elevance Health Inc. (ELV) | $3,020,930 | 5 | 17.10% | $86.88B |
| Increased Positions | 880 | +53.01% | 16M | +7.52% |
| Decreased Positions | 707 | -42.59% | 16M | -7.83% |
| New Positions | 218 | New | 4M | New |
| Sold Out Positions | 157 | Sold Out | 3M | Sold Out |
| Total Postitions | 1,833 | +10.42% | 206M | -0.32% |
| Vanguard Group Inc | $8.81M | 9.51% | 21.49M | +138,380 | +0.65% | 2024-12-31 |
| Blackrock, Inc. | $8.74M | 9.43% | 21.31M | +868,829 | +4.25% | 2025-03-31 |
| State Street Corp | $4.38M | 4.73% | 10.68M | -5,705 | -0.05% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $4.35M | 4.7% | 10.62M | +464,137 | +4.57% | 2024-12-31 |
| Wellington Management Group Llp | $2.61M | 2.81% | 6.36M | +2M | +42.45% | 2024-12-31 |
| Geode Capital Management, Llc | $2.04M | 2.2% | 4.96M | +115,971 | +2.39% | 2024-12-31 |
| Sanders Capital, Llc | $1.92M | 2.07% | 4.69M | +76,896 | +1.67% | 2024-12-31 |
| Capital International Investors | $1.59M | 1.72% | 3.88M | +35,576 | +0.93% | 2024-12-31 |
| First Eagle Investment Management, Llc | $1.32M | 1.43% | 3.23M | +1M | +47.56% | 2024-12-31 |
| Norges Bank | $1.26M | 1.36% | 3.08M | +28,533 | +0.94% | 2024-12-31 |